Deutsch English Français

Contact

EP1222265

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1222265

EP1222265 - NOVEL NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT, ITS ISOLATION AND USE [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 23.12.2011 Database last updated on 11.05.2024
Most recent event Tooltip	17.05.2013	Lapse of the patent in a contracting state New state(s): LU	published on 19.06.2013 [2013/25]
Applicant(s)	For all designated states SANOFI 174, Avenue de France 75013 Paris / FR
	[2011/30]
Former [2004/44]	For all designated states Sanofi-Aventis 174, Avenue de France 75013 Paris / FR
Former [2002/29]	For all designated states SANOFI-SYNTHELABO 174, Avenue de France 75013 Paris / FR
Inventor(s)	01 / BESNARD, François 5, rue du Colonel Fabien F-78220 Viroflay / FR
	02 / CHARPANTIER, Eric 49 Avenue Paul Morin F-92000 Nanterre / FR
	03 / SGARD, Frédéric 2 Avenue Beauséjour F-92500 Rueil Malmaison / FR
	[2002/29]
Representative(s)	Monain, Patrice, et al Sanofi aventis Departement Brevets Base Business 46 Quai de la Rapée 75601 Paris cedex 12 / FR
	[N/P]
Former [2002/29]	Monain, Patrice, et al Sanofi-Synthelabo, 174 avenue de France 75013 Paris / FR
Application number, filing date	00951509.9	08.08.2000
	[2002/29]
	WO2000EP07918
Priority number, date	EP19990402371	29.09.1999 Original published format: EP 99402371
	[2002/29]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO0123551
	Date:	05.04.2001
	Language:	EN
	[2001/14]
	Type:	A1 Application with search report
	No.:	EP1222265
	Date:	17.07.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 05.04.2001 takes the place of the publication of the European patent application.
	[2002/29]
	Type:	B1 Patent specification
	No.:	EP1222265
	Date:	16.02.2011
	Language:	EN
	[2011/07]
Search report(s)	International search report - published on:	EP	05.04.2001
Classification	IPC:	C12N15/12, C12N5/10, C07K14/705, C07K16/28, C12Q1/68, G01N33/50, G01N33/566, A61K31/70, A61K38/17, A61P25/00	[2002/29]
	CPC:	C07K14/70571 (EP); A61P25/00 (EP); A61K38/00 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/29]
Title	German:	NICOTIN-ACETYLCHOLIN REZEPTORUNTEREINHEIT, DEREN ISOLIERUNG UND VERWENDUNG	[2002/29]
	English:	NOVEL NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT, ITS ISOLATION AND USE	[2002/29]
	French:	NOUVELLE SOUS-UNITE DE RECEPTEUR NICOTINIQUE DE L'ACETYLCHOLINE, ISOLEMENT ET UTILISATION DE CELLE-CI	[2002/29]
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	29.04.2002	National basic fee paid
	29.04.2002	Designation fee(s) paid
	29.04.2002	Examination fee paid
Examination procedure	19.04.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	29.04.2002	Examination requested [2002/29]
	07.08.2003	Despatch of a communication from the examining division (Time limit: M06)
	16.02.2004	Reply to a communication from the examining division
	03.06.2004	Despatch of a communication from the examining division (Time limit: M06)
	10.12.2004	Reply to a communication from the examining division
	28.11.2006	Despatch of a communication from the examining division (Time limit: M06)
	07.06.2007	Reply to a communication from the examining division
	24.08.2010	Communication of intention to grant the patent
	22.12.2010	Fee for grant paid
	22.12.2010	Fee for publishing/printing paid
Opposition(s)	17.11.2011	No opposition filed within time limit [2012/04]
Fees paid	Renewal fee
	27.08.2002	Renewal fee patent year 03
	26.08.2003	Renewal fee patent year 04
	26.08.2004	Renewal fee patent year 05
	30.08.2005	Renewal fee patent year 06
	31.08.2006	Renewal fee patent year 07
	14.08.2007	Renewal fee patent year 08
	31.03.2008	Renewal fee patent year 09
	12.08.2009	Renewal fee patent year 10
	17.08.2010	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	16.02.2011
	FI	16.02.2011
	GR	17.05.2011
	IE	08.08.2011
	LU	08.08.2011
	MC	31.08.2011
	[2013/25]
Former [2012/35]	CY	16.02.2011
	FI	16.02.2011
	GR	17.05.2011
	IE	08.08.2011
	MC	31.08.2011
Former [2012/18]	CY	16.02.2011
	FI	16.02.2011
	GR	17.05.2011
	MC	31.08.2011
Former [2011/40]	CY	16.02.2011
	FI	16.02.2011
	GR	17.05.2011
Former [2011/36]	GR	17.05.2011
Cited in	International search	[X]WO9603504 (SALK INST FOR BIOLOGICAL STUDI [US]) [X] 1-3,9,12-15,22-26 * abstract * * claims 1-34 * * figure 1B * * figure 3B *;
		[A]WO9641876 (SIBIA NEUROSCIENCES INC [US], et al) [A] 1-16,19,22-29 * abstract * * claims 1-52 *;
		[A]US5599709 (LINDSTROM JON M [US], et al) [A] 1-16,19,22-29 * abstract ** claims 1-22 *;
		[X] - "EST; H. sapiens cDNA clone IMAGE:2345519 similar to neuronal acetylcholine receptor protein alpha-9 chain precursos", EMBL SEQUENCES, EMBL, Heidelberg, FRG, (19990519), XP002131223 [X] 1-16,19,22-29 * covers nt 594-1134 of seq. ID 1 (HNAR10) *
		[PXD] - CHARPANTIER E., "Homo sapiens NARA9 gene", EMBL SEQUENCES, (20000107), XP002153207 [PXD] 22-26,28,29 * the whole document *
		[ ] - BESNARD F. ET AL., "Cloning and characterization of the human alpha-9 nicotinic receptor.", SOCIETY FOR NEUROSCIENCE ABSTRACTS, (1999), vol. 25, page 1720, XP000960908 [ ] * abstract *
	by applicant	WO9603504
		- BARNARD, E., TIBS, (1992), vol. 17, pages 368 - 374
		- GALZI, J.-L.; CHANGEUX, J. -P., NEUROPHARMACOL, (1995), vol. 34, no. 6, pages 563 - 582
		- WILLIAMS, M. ET AL., DRUGS NEWS PERSPECT., (1994), vol. 7, pages 205 - 223
		- LINDSTROM, J., MOL. NEUROBIOL., (1997), vol. 15, no. 2, pages 193 - 222

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p